MedPath

Comparison Study for Bioelectrical Impedance Device to Measure Human Body Composition

Not Applicable
Completed
Conditions
Body Composition Measurement
Interventions
Device: Akern USA EFG
Device: RJL Impedance analyzer
Registration Number
NCT00956917
Lead Sponsor
Akern USA LLC
Brief Summary

The purpose of this study is to determine if the ElectroFluidGraph(tm) (EFG) impedance analyzer is comparable to a predicate device in measuring human body composition.

Detailed Description

The purpose of this study is to determine if the ElectroFluidGraph(tm) (EFG) impedance analyzer is comparable to a predicate device in measuring human body composition under normal patient conditions. Specifically, the goal of this study is to compare impedance measurements (R and Xc) determined by using each bioelectrical impedance device and the estimated body compositional estimates \[total body water (TBW); fat-free mass (FFM); and fat mass (FM)\] calculated by using the same prediction equation (models) as the predicate device.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
109
Inclusion Criteria
  • Healthy individuals
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Akern EFGAkern USA EFG-
RJL deviceRJL Impedance analyzer-
Primary Outcome Measures
NameTimeMethod
Resistance (R) - (ohms)5 minutes
Secondary Outcome Measures
NameTimeMethod
Fat Free Mass (FFM)5 minutes
Total Body Water (TBW)5 minutes
Extra Cellular Water5 minutes
Fat Mass (FM)5 minutes

Trial Locations

Locations (1)

Laboratorio, FIGC, Settore Tecnico Coverciano

🇮🇹

D'Annunzio, Florence, Italy

© Copyright 2025. All Rights Reserved by MedPath